Trastuzumab stands as one of the most significant breakthroughs in modern oncology, fundamentally changing the treatment landscape for HER2-positive cancers, most notably breast and gastric cancer. Unlike traditional chemotherapy, which attacks all rapidly dividing cells, trastuzumab is a targeted therapy—a monoclonal antibody precision-engineered to seek out and block cancer cells that overexpress the HER2 receptor. […]
Controlling bleeding during surgery is one of the most important parts of any medical procedure. Excess bleeding can increase operation time, reduce visibility for the surgeon, and may increase the risk of complications. Because of this, modern surgical practice often uses advanced hemostatic agents when conventional methods are not enough. One such product used in […]
Tishtha 40mg Injection (Nivolumab): A Trusted Generic Alternative to Opdivo® Cancer treatment has entered a new era with the rise of immunotherapy, offering patients improved survival and better quality of life compared to conventional chemotherapy. Tishtha 40mg Injection, containing Nivolumab, is a high-quality generic alternative to Opdivo® (Opdyta) and is widely used in modern oncology […]
Overview Soliris 300 mg Injection is a groundbreaking monoclonal antibody therapy used for managing rare but serious medical conditions caused by uncontrolled activation of the complement system. Containing Eculizumab, Soliris is the first-in-class terminal complement inhibitor approved for several life-threatening diseases. Approved by the FDA, EMA, and regulatory authorities globally, Soliris has transformed the treatment […]
Introduction Colorectal cancer remains one of the leading causes of cancer-related deaths worldwide. For patients with advanced stages of the disease—particularly those who have exhausted first-line and second-line treatment options—new therapies offer a potential extension of life and symptom control. One such targeted therapy is Elunate, which contains the active pharmaceutical ingredient fruquintinib. What is […]